Activation of Human Mesenchymal Stem Cells Impacts Their Therapeutic Abilities in Lung Injury by Increasing Interleukin (IL)-10 and IL-1RN Levels

Acute respiratory distress syndrome (ARDS) is an important cause of morbidity and mortality, with no currently effective therapies. Several preclinical studies have shown that human mesenchymal stem cells (hMSCs) have therapeutic potential for patients with ARDS because of their immunomodulatory pro...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Bustos, Martha L., Huleihel, Luai, Meyer, Ernest M., Donnenberg, Albert D., Donnenberg, Vera S., Sciurba, Joseph D., Mroz, Lyle, McVerry, Bryan J., Ellis, Bryon M., Kaminski, Naftali, Rojas, Mauricio
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: AlphaMed Press 2013
Gaiak:
Protocols and Manufacturing for Cell-Based Therapies
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3808203/
https://ncbi.nlm.nih.gov/pubmed/24089414
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5966/sctm.2013-0033
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak